National Marrow Donor Program

Running trials

• Active, not recruiting

  Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma

  NCT03922724· Phase 2· Source

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

  NCT02356159· Phase 1/2· Source

• Completed

  Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell Transplantation

  NCT01087294· Phase 1· Source

Trial sites

• National Marrow Donor Program3 trials

Conditions

Diseases this institution publishes on or runs trials for.

• Myelodysplastic syndromes26 works · 1 trials